A detailed history of Lion Street Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lion Street Advisors, LLC holds 10,228 shares of PFE stock, worth $268,075. This represents 0.1% of its overall portfolio holdings.

Number of Shares
10,228
Previous 10,500 2.59%
Holding current value
$268,075
Previous $293,000 0.68%
% of portfolio
0.1%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$27.7 - $31.39 $7,534 - $8,538
-272 Reduced 2.59%
10,228 $295,000
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $7,982 - $9,353
316 Added 3.1%
10,500 $293,000
Q4 2023

Jan 09, 2024

SELL
$26.13 - $33.94 $56,440 - $73,310
-2,160 Reduced 17.5%
10,184 $293,000
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $55,964 - $65,417
1,744 Added 16.45%
12,344 $409,000
Q2 2023

Jul 28, 2023

BUY
$36.12 - $41.79 $111,863 - $129,423
3,097 Added 41.28%
10,600 $388,000
Q1 2023

Apr 12, 2023

BUY
$39.39 - $51.28 $40,492 - $52,715
1,028 Added 15.88%
7,503 $306,000
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $250 - $327
-6 Reduced 0.09%
6,475 $0
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $262 - $320
6 Added 0.09%
6,481 $280,000
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $837 - $993
-18 Reduced 0.28%
6,475 $280,000
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $823 - $1,020
18 Added 0.28%
6,493 $337,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $254,143 - $326,469
6,475 New
6,475 $276,000
Q2 2020

Jul 20, 2020

SELL
$30.12 - $36.54 $25,089 - $30,437
-833 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $22,515 - $32,170
833 New
833 $27,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lion Street Advisors, LLC Portfolio

Follow Lion Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lion Street Advisors, LLC with notifications on news.